Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • trelek2
    Junior Member
    • May 2013
    • 2

    cross-species data - questions about normalization

    Hi,

    I have some data form various samples (cell types) in different species.
    I want to compare and analyze gene expression variability across the different species.

    I've plotted the average expression (tags per million 'tpm' data) for each sample. I found that the average expression is more or less the same for all samples from a given species but the average expression values vary across species greatly (for example all human samples are about 20 and all mouse samples are about 25 but all dog samples are at about 100 tmp).

    I'm guessing that this is because the data is not normalized and therefore the data is not comparable before performing a normalization.

    I tried using different recently developed methods for data normalization (RLE, TMM) implemented in EdgeR as well as DeSeq and normalized the data from different species (by entrez id) separately for each cell type. This however still does not give much more similar average expressions for the different species. The averages of samples from the same species have now become much more dissimilar.

    The only samples that went to a similar average expression level across the different species is Universal RNA - which is a mix of different tissues rather than a specific cell type.


    I'm really confused, does the above mean the normalization is fine and I shouldn't worry about the fact that average expression values between different species are dissimilar, or does this rather imply something is wrong?

    Maybe I should normalize by ignoring the gene ids and just looking at the whole expression profile (negative binomial) by sorting the genes according to their expression values and then having a different normalization factor for every expression value, whichever gene it is in every sample, so that I end up with 2 negative binomial curves that look the same but the genes on the x axis will be differently ordered depending on the species?

    thanks.
  • mbblack
    Senior Member
    • Aug 2009
    • 245

    #2
    Does each species have it's own controls? In other words, can each species be analyzed as an independent experiment?

    If so, you could normalize each independently, analyze differential expression in each independently, and then simply compare homologous genes amongst the significantly differentially expressed genes in each species. I would suggest basing significance in each of the three independent analyses by simultaniously applying a statistical and a fold change cutoff to get the most robust differential gene lists for each.

    That's how I've dealt with comparisons between, for example, rat and human hepatocytes exposed to dioxin. Set up the experiments separately and analyzed each species as an independent differential gene expression experiment, then compare the analyzed gene lists for significant homologous genes in each.

    Otherwise, you have a very complex normalization situation where you may have to perform independent normalizations for each species followed by some form of scaling correction/normalization for the meta-analysis of all three.
    Last edited by mbblack; 05-23-2013, 07:32 AM.
    Michael Black, Ph.D.
    ScitoVation LLC. RTP, N.C.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Working...